Background: In The Netherlands, 1168 Q-fever patients were notified in 2007 and 2008. Patients and general practitioners (GPs) regularly reported persisting symptoms after acute Q-fever, especially fatigue and long periods of sick leave, to the public health authorities. International studies on smaller Q-fever outbreaks demonstrate that symptoms may persist years after acute illness. Data for the Dutch outbreaks were unavailable. The aim of this study is to quantify sick leave after acute Q-fever and long-term symptoms. Methods: Our study targeted 898 acute Q-fever patients, notified in 2007 and 2008 residing in the Province Noord-Brabant. Patients from the 2008 cohort were mailed a questionnaire at 12 months and those of the 2007 cohort at 12-26 months after onset of illness. Patients reported underlying illness, Q-fever-related symptoms and sick leave. Results: The response rate was 64%. Forty percent of the working patients reported long-term (>1 month) sick leave. Pre-existent heart disease odds ratio (OR) 4.50; confidence interval (CI) 1.27-16.09), hospitalization in the acute phase (OR 3.99; 95% CI 2.15-7.43) and smoking (OR 1.69; 95% CI 1.01-2.84) were significant predictors for long-term absence. Of the patients who resumed work, 9% were-at the time of completing the questionnaire-still unable to function at pre-infection levels due to fatigue or concentration problems. Of the respondents, 40% reported persisting physical symptoms at the time of follow-up. Fatigue (20%) was most frequently reported. Daily activities were affected in 30% of cases. Conclusions: Q-fever poses a serious persisting long-term burden on patients and society. 
Introduction

Q
-fever is a worldwide zoonotic disease caused by Coxiella burnetii, an obligate intracellular bacterium. In The Netherlands, Q-fever was uncommon before 2007 with 10-20 notified cases annually. 1 Since 2007 and up to December 2010, more than 4000 cases 2 were notified in four major outbreaks implicating dairy goats as the source. 1, [3] [4] [5] Approximately 80% of the notified Q-fever patients reside in Noord-Brabant, the province with the highest dairy goat density in The Netherlands.
Coxiella burnetii is common in a wide range of wild and domestic animals but only small ruminants, in particular sheep and goats, are associated with large human outbreaks. 6, 7 Infected animals excrete billions of bacteria in birth products and to a lesser extent in faeces, urine and milk. Human infection occurs mainly after inhaling dust particles contaminated with C. burnetii.
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In susceptible individuals, infection develops after a mean incubation period of 21 days. 6 In general, 60% of the infected Q-fever patients are asymptomatic, whereas 20% of the patients develop mild symptoms. Another 20%, however, present with more severe symptoms ranging from high fever, severe headache, night sweating, nausea, diarrhoea, pneumonia, hepatitis, pericarditis, myocarditis and neurological symptoms. 8 Chronic Q-fever may develop in up to 5% of acute cases 9-11 due to a reactivation of Coxiella. A follow-up of 686 Dutch acute Q-fever patients from 2007 to 2008 finds that 1.6% converted to chronic Q-fever. 12 A feared presentation of chronic Q-fever is endocarditis 11 that may take 10-15 years to develop. Pregnant women and people with heart valve disorders, vascular prosthesis or impaired immunity have a higher risk to develop a chronic infection.
Q-fever patients may develop Q-fever fatigue syndrome (QFS), a debilitating fatigue out of proportion with exertion that may last up to 10 years. 13, 14 Post-infection fatigue 15 is not unique for Q-fever. It may also occur after other infectious diseases such as Lyme disease, EpsteinBarr virus infection, 16 legionnaires disease 17 and other pneumonias. 18 Anecdotal information suggests that patients from the 2007 cohort had a more severe course of illness compared with those from the 2008 outbreak and were longer absent from work. However, evidence on the recovery of patients from the Dutch 2007 and 2008 cohorts is lacking. This study aims to fill that gap. The first objective is to assess the duration of sick leave after an episode of acute Q-fever-in 2007 or 2008-and the long-term self-reported symptoms and associated risk factors. The second objective is to assess differences between the two cohorts for the duration of self-reported sick leave and the occurrence and frequency of long-term health symptom.
Methods
Study design and population
The population for this cohort study consisted of 898 patients notified in 2007 and 2008 to the Municipal Health Services 'Hart voor Brabant' and 'Brabant Zuid-Oost'. Due to incomplete data or an unknown month of onset of illness, 28 patients were excluded (figure 1). The remaining 870 Q-fever patients fitted the Dutch notification criteria; a laboratory confirmation of Q-fever and clinical presentation with fever, pneumonia or hepatitis.
Data collection
In February 2009, all patients received a study information folder including a participation request and consent form by post ( figure  1 ). Patients could state their willingness to take part in any of a number of studies under the so-called Q Quest-1 project, by signing and returning the consent form. Participating patients received a questionnaire-by postal mail-focusing on demographic characteristics, medical history, smoking behaviour, current Q-fever-related physical symptoms and employment-related items, such as duration of sick leave following acute Q-fever, resumption and current ability to work (employed, selfemployed, volunteer work, household work). During a pre-test, the completion of the questionnaire took 20-30 min.
All patients from the 2007 cohort received the questionnaire in February 2009 (13-26 months after onset of Q-fever illness). Patients notified in 2008 were mailed a questionnaire 1 year after the month of onset of illness. Patients from both cohorts received two reminders after 3 and 6 weeks. We obtained data on non-responders regarding gender, age, year of onset of disease and hospitalization from the notification data of the Municipal Health Services.
Data analysis
Questionnaires were double scanned and data were cleaned. Statistical analysis was done using SPSS 16 for windows. We used the MantelHaenzel 2 test and Fisher's exact test to compare proportions. Pvalues are based on two-tailed tests with a P < 0.05 defined as significant. The notification data of the Municipal Health Services were used to compare responders and non-responders for age, gender, year of onset of illness and hospitalization.
Multivariate logistic regression was used to model the relationship between outcome (sick leave >1 month or presence of symptoms) and the independent variables age, gender, hospitalization, underlying diseases and year of onset of illness. Multivariate logistic regression was used to model the relationship between the determinants year of onset of illness and hospitalization with the outcomes presence of symptoms (fatigue) and long-term sick leave. For the potential confounders, age, gender, smoking and co-morbidity, we used the same model.
Results
Patient participation
The overall response rate was 63.9% (figure 1). The mean time between the day of onset of illness and receiving the questionnaire was 19.5 months (SD 2.3) for patients of the 2007 cohort and 12.1 months (SD 0.5) for patients of the 2008 cohort. We were informed that five patients died, but had no information on the cause of death.
The response rate of men was lower than that of women as was that of younger ( 30 years of age) compared with older patients (>30 years of age). There were no differences between responders and non-responders for year of onset of illness and hospitalization (see Supplementary table S1 for details).
Characteristics of the study population
The study population (table 1) 
Sick leave
Prior to the Q-fever infection 62% of the study population was gainfully employed. During the episode of acute fever, 91.3% of these patients reported sick for work (figure 2). Overall, 132 (39.6%) of the study subjects who worked prior to the infection were longer than 1 month (long-term sick leave) absent from work following an acute Q-fever infection. See Supplementary table S2 for sick leave of the gainfully employed, volunteers and those who do household work.
Hospitalization, smoking and underlying heart disease were independent predictors for long-term sick leave (table 2) . Gender, age, year of onset of illness, underlying lung disease, depression or level of education were not significantly related to long-term sick leave (table 2).
Self-reported symptoms
Almost 40% of the patients reported at least one current health complaint at the time of follow-up that they perceived to be Q-fever-related (Supplementary table S3 ). The most frequently reported symptoms were: fatigue, 19.8%; difficulty concentrating, 9.5%; muscle pain, 9.0%; and night-time sweating, 7.9%. Women (OR 1.84, 95% CI 1.27-2.67; P = 0.001) were more likely to report symptoms than men. For fatigue, this was 25.1% of women vs. 16.2% among men.
The 2007 and 2008 cohorts were similar in number, type and frequency of reported symptoms (Supplementary table S3 ). Multivariate logistic regression showed that year of onset of illness was not significantly related to the reporting of a health complaint, when controlling for differences in age, smoking, underlying heart/lung disease and depression. Women and patients that had been hospitalized or suffered depression were more likely to report fatigue at the time of follow-up (table 2) .
Long-term sick leave, resumption of work or daily activities in relation to perceived Q-fever-related health symptoms
Study subjects (N = 132, 39.6%) that were longer than 1 month (long-term sick leave) absent from work following an acute Q-fever infection showed more fatigue at 12-26 months after initial illness than patients with a shorter absence.
Of the patients that resumed work, 9.3% reported that they were unable to function at pre Q-fever levels at the time they completed the questionnaire, due to perceived Q-fever-related health symptoms, mainly fatigue and concentration problems. Almost one-third of the patients (29.0% of the 2007 cohort and 33.1% of the 2008 cohort), reported that they had not fully resumed their daily activities at 12-26 months 
Discussion
We analysed data from notifications and questionnaires of 556 Q-fever patients notified in 2007 and 2008 in The Netherlands. Our most important findings were that after an episode of acute Q-fever, two out of five patients were over a month absent from work. We found that hospitalization in the acute phase, underlying heart disease and smoking behaviour were independent predictors for sick leave exceeding a month. Almost, 1 in 10 patients were unable to function at pre Q-fever infection level at the time of the questionnaire mainly due to fatigue and concentration problems. Two out of five patients reported Q-fever-related symptoms and one-third indicated that they had not resumed their daily activities to the pre Q-fever infection level.
Work and sick leave
To our knowledge, this is the first time that data on Q-fever and sick leave following a Q-fever outbreak are presented. We are therefore unable to compare the results with other studies on Q-fever patients. We do, however, know that in The Netherlands the average duration of sick leave per employee was 6.3 days 19 in 2008. One in three Dutch patients with sick leave have a cold or flu-like symptoms, but are rarely longer than 1 week absent from work. 19 In a large cross-sectional study, 20 16% of the Dutch employees reported >9 days sick leave per year. In our study, 57% of Q-fever patients reported >9 days sick leave per year.
Patients that reported persisting fatigue at 12-26 months, were also significantly more often long-term absent from work due to sick leave following the acute infection. Our findings are in line with a study from Huibers et al. 21 that showed that persisting fatigue has a strong correlation with sickness absence exceeding 42 days.
Symptoms
One to 2 years after acute Q-fever, two-thirds of the patients still reported symptoms that they attributed to Q-fever. Cohorts did not differ in the overall reported symptoms and specific symptoms. We had expected to find a difference in symptoms between the cohorts as clinicians often reported that patients of the 2007 cohort had more serious illness. Due to methodological reasons (see under 'Methodological considerations and study limitations limitations' section), we are unable to asses if the 2007 cohort initially had more symptoms during the convalescence period and partially recovered or that the level of persistent symptoms was similar for both cohorts.
Hatchette and Hayes 22 reported 51% of the Q-fever patients with persistent symptoms 26 months after the acute Q-fever episode. Ayres et al.
14 studied a cohort of 71 Q-fever patients and found that 5 years after the initial infection up to 68% of study subjects presented with symptoms. Our findings are in line with these two studies. It may be questioned whether long-term persistence of symptoms is unique for Q-fever. In a study of patients with community-acquired pneumonia (of varying degrees of severity), a full recovery was reported after 6-18 months. Persistence of symptoms was mostly attributed to morbidity that existed before the pneumonia episode. 18 In our study, patients with pre-existent heart or lung disease had similar outcomes for persisting symptoms than those without pre-existent disease. 
Number of weeks after initial illness due to Q-fever at which work was resumed Percentage of patients that resumed work
Percentage of men that resumed work
Percentage of women that resumed work Figure 2 The week of self-reported work resumption after sick leave following an episode of acute Q-fever in 334 workers
Fatigue
In the present study, 19.8% of the Q-fever patients report fatigue 12-26 months after the onset of illness, without a significant difference between both cohorts. Although patients from the 2007 cohort were more often hospitalized and our study shows that hospitalization in the past-due to Q-fever-is significantly related to fatigue 12-26 months later, it appeared that the year of onset of illness did not influence long-term fatigue.
In another study, 23 on these same patients, we found that when using a validated instrument, the NCSI (Nijmegen Clinical Screening Instrument) 24, 25 up to 43.5% of the patients stated fatigue. Other studies also report much higher rates of 52% 26 undue tiredness after 1 year, 51% up to 5 years later 14 or even 64% 10 years after Q-fever infections. 13 We therefore suspect that the outcome is related to the way the information on fatigue is gathered.
Our finding that patients who reported fatigue had been more often hospitalized is in line with Hickie et al. 27 who report that the key risk factor for post-infective fatigue syndromes is the severity of the acute illness. In their study, they found no age, sex-related or psychological risk factors. We found, however, that women and patients with depression reported more fatigue. Depression has two components: 28 a somatic factor often expressed as fatigue and a depression factor. The dominating factor may determine the diagnosis. In our study, we could not make a distinction between the two as we did not ask additional questions. Different co morbidities-including chronic fatigueassociated with depression can be explained by (neuro) inflammatory and oxidative and nitrosative stress path ways. 29 Unexplained fatigue and depression might act as independent risk factors of each other. 30 The question is whether the explainable fatigue caused by Q-fever might be a pre-curser to depression.
Women also reported other symptoms significantly more often. This does not necessarily mean that women have more symptoms, as woman are known to present symptoms more often. 31 We did not medically examine patients and could not establish whether the fatigue fulfilled the diagnostic criteria of the chronic fatigue syndrome (CFS).
32, 33 Nor did we have information on the duration, the severity of the fatigue, the presence of tender lymph nodes or possible other causes.
Cohort comparison
Patients from the 2007 cohort received the questionnaire later (13-26 months after the acute episode) than those of the 2008 cohort (at 12 months). Therefore, data from the two cohorts are not entirely comparable as we are unable to assess the initial level of symptoms of the 2007 cohort.
The hospitalization rate was much higher for the 2007 cohort (43.8%) than for the 2008 cohort (19.5%). This shows that our study population is in this respect a good representation of the notified Q-fever patients as mandatory notification data show that the hospitalization rate for our area was 43.7% in 2007 and 16.3% in 2008. This is much higher than the rate of 2-3% reported in literature. 34 The high percentage of hospitalized patients in 2007 was largely influenced by active case finding in a retrospective survey among hospitalized cases. 35 Both patients and clinicians recognized and diagnosed Q-fever more readily in 2008, when it had become apparent that this previously uncommon disease presented more often in the area. Only the very ill patients might have been recognized and diagnosed by clinicians in 2007.
Although hospitalized patients reported more long-term fatigue and sick leave, we did not find an independent significant relation between cohort and reported fatigue or sick leave.
Methodological considerations and study limitations
A limitation of this study is that we lacked a control group. The reason was that this study was designed as a cost of illness study rather than an aetiological study.
One of the complexities of this study is that we were dealing with many confounders such as age, gender and co-morbidity; for example, heart disease, depression and health symptoms such as fatigue. Our determinants of interest were, however, hospitalization and the year of onset of illness.
The response rate was significantly higher for woman and patients older than 30 years this is in line with survey response rates in the Netherlands. 36 Due to this selection bias, the percentage of fatigue found in this study might be slightly higher than that in the total Qfever population. Access to pre-Q-fever health status and sick leave data would have been ideal but these data were unavailable. Therefore, we can not proof if all reported sick leave and health symptoms are completely related to Q-fever.
In the absence of other data, our data give a valuable insight into sick leave and symptoms related to Q-fever. One could question whether these symptoms were caused by Q-fever because symptoms of Q-fever may not be very specific. By asking per symptom whether the symptom was present, we might have prompted patients which could have led to over reporting. The same could have applied to co-morbidity.
Although we asked questions on past or initial symptoms, we only analysed current symptoms thereby omitting problems with recall bias.
For sick leave, we cannot exclude recall bias as we asked patients to recall their sick leave up to 26 months after an episode of acute Q-fever. Many patients were, however, very precise and even stated dates of sick leave. Although we asked patients about productivity loss at work, we did not use a validated instrument and can therefore not directly compare our findings with other studies.
Data on sick leave were only available for responders. This might have biased the results on sick leave. Although we are not sure about that, we do have some indications about the validity of our findings. The strongest indication is that the hospitalization rate, one of the most important determinants of the duration of sick leave, was similar for responders and non-responders.
Conclusions
The negative impact of Q-fever on productivity and perceived health status is considerable, especially when taking the high incidence in certain communities into account. Hospitalization, as an indicator of severity of the acute illness, turned out to be a strong independent predictor for long-term sick leave and persistent fatigue in Q-fever patients.
This study demonstrates the considerable burden of disease from Q-fever for individual patients, families and society.
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